SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-010627
Filing Date
2023-03-29
Accepted
2023-03-29 16:24:20
Documents
79
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K antx-20221231.htm   iXBRL 10-K 3814252
2 EX-4.3 antx-ex4_3.htm EX-4 53751
3 EX-10.17 antx-ex10_17.htm EX-10 47876
4 EX-10.18 antx-ex10_18.htm EX-10 49904
5 EX-23.1 antx-ex23_1.htm EX-23 6901
6 EX-31.1 antx-ex31_1.htm EX-31 19187
7 EX-31.2 antx-ex31_2.htm EX-31 18910
8 EX-32.1 antx-ex32_1.htm EX-32 11199
9 EX-32.2 antx-ex32_2.htm EX-32 11189
10 GRAPHIC img90168601_0.jpg GRAPHIC 20460
11 GRAPHIC img90168601_1.jpg GRAPHIC 34440
12 GRAPHIC img90168601_2.jpg GRAPHIC 31657
  Complete submission text file 0000950170-23-010627.txt   11198030

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT antx-20221231_def.xml EX-101.DEF 211148
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT antx-20221231_pre.xml EX-101.PRE 356994
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT antx-20221231.xsd EX-101.SCH 58125
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT antx-20221231_cal.xml EX-101.CAL 46105
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT antx-20221231_lab.xml EX-101.LAB 467862
73 EXTRACTED XBRL INSTANCE DOCUMENT antx-20221231_htm.xml XML 1729943
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41331 | Film No.: 23775551
SIC: 2834 Pharmaceutical Preparations